More different studies showed its beneficial effects on several other diseases such as diabetes, vascular calcifications and consequently reduced risk of cardiovascular events, coronary heart disease, Parkinsons disease, and kidney stones treatment
Anti-rebound strategies should be integrated into the clinical pathway, including intensified lifestyle maintenance and, where appropriate, sequential metformin to maintain metabolic stability
consult a physician before use
The Realistic Timeline The FDA approved the Wegovy pill on December 22, 2025 and the medication should be available to patients in early January 2026
407 GLP-1 inhibits glucose uptake in astrocytes and promotes beta-oxidation, which is essential for regulating energy balance in the brain and maintaining mitochondrial integrity